"Atypical" virus discovered to be driver of certain kidney diseases

September 14, 2018, Medical University of Vienna
This image shows a cross section of a kidney. Credit: Holly Fischer/Wikipedia

An international research team led by Wolfgang Weninger has discovered a previously unknown virus that acts as a "driver" for certain kidney diseases (interstitial nephropathy). This "atypical" virus, which the scientists named "MKPV" (for Mouse Kidney Parvovirus), belongs to the family of parvoviruses. The results of the study have now been published in the leading international journal Cell.

Background to the discovery: "Over the last few years, a spontaneous occurred in laboratory mice at our institute. Specifically, immunodeficient animals, that is to say animals with an inborn immune system disorder, were dying suddenly and prematurely from the condition. We were able to pinpoint the disease as a problem of the renal tubules," explains Weninger. And this so-called interstitial tubulopathy is triggered by MKPV. "MKPV-induced closely resembles a similar form of viral tubulopathy, which can occur in patients following a transplant," explains the MedUni Vienna immunology expert.

The researchers therefore have at hand a new model for studying viral kidney diseases, and . In contrast to previously used models, which are primarily based on surgical interventions or the administration of toxic substances, MKPV infection is a natural model, very similar to the chronic course of renal failure in humans. This model can now be used to test new drugs to combat renal fibrosis and tubulopathies. It will also be possible to discover new biomarkers for these diseases and develop them for clinical application.

Says Weninger: "Going forward, we will now be working on the question as to whether similar viruses also lead to kidney infections or in humans, especially in immunosuppressed patients following a ." The MKPV virus could also be used for the purposes of gene therapy, in order to repair genes in renal tubules. This is because MKPV infects very specific cells in the kidneys (renal tubules) but no other cells in the body. One could therefore use a non-infectious variant of the virus to deliver or replace genes in kidney cells.

About nephropathy

Nephropathy is a blanket medical term for various inflammatory and non-inflammatory kidney diseases. The commonest form is diabetic nephropathy. This is a condition whereby the kidneys can be damaged as a result of long-term diabetes. If blood glucose is poorly controlled over a period of many years, it ends up damaging the small blood vessels in the kidneys. However, nephropathy can also occur in connection with other diseases, such as high blood-pressure, or be caused by certain drugs or infections.

Explore further: Acute critical illness increases risk of kidney complications and death

More information: Ben Roediger et al. An Atypical Parvovirus Drives Chronic Tubulointerstitial Nephropathy and Kidney Fibrosis, Cell (2018). DOI: 10.1016/j.cell.2018.08.013

Related Stories

Acute critical illness increases risk of kidney complications and death

September 10, 2018
Acute critical illness in people without previous renal disease puts them at risk of kidney complications as well as death, according to a study in published in CMAJ (Canadian Medical Association Journal).

New tools to combat kidney fibrosis

October 16, 2017
Interstitial fibrosis – excessive tissue scarring – contributes to chronic kidney disease, which is increasing in prevalence in the United States.

Recent change in spectrum of HIV-linked kidney disease

December 14, 2017
(HealthDay)—The spectrum of HIV-associated kidney disease has changed with the improvement of therapy for HIV infection, according to a review article published in the Dec. 14 issue of the New England Journal of Medicine.

Study will test new treatments for life-threatening kidney condition IgA nephropathy

June 28, 2018
A patient from Birmingham is the first person to be recruited into a new worldwide study to test new treatments for a potentially life-threatening kidney condition called IgA nephropathy. The research team responsible for ...

Will blocking IL-17A help treat kidney disease?

January 22, 2016
Many different diseases and insults can injure kidneys, resulting in kidney failure. Some autoimmune diseases damage glomeruli (the 'filtering units' of the kidney), while problems with the tubules (for example, impaired ...

Research aims to prevent diabetic kidney failure

November 5, 2011
The enzyme arginase-2 plays a major role in kidney failure, and blocking the action of this enzyme might lead to protection against renal disease in diabetes, according to researchers.

Recommended for you

Separated entry and exit doors for calcium keep energy production smooth in the powerhouses of heart cells

September 18, 2018
Stress demands the heart to work harder and faster. To keep pace, the muscle must make its fuel at an accelerated rate. Bursts of calcium entering mitochondria—the cell's powerhouses—normally help control energy output, ...

First gut bacteria may have lasting effect on ability to fight chronic diseases

September 18, 2018
New research showing that the first bacteria introduced into the gut have a lasting impact may one day allow science to adjust microbiomes—the one-of-a-kind microbial communities that live in our gastrointestinal tracts—to ...

A new defender for your sense of smell

September 18, 2018
New research from the Monell Center increases understanding of a mysterious sensory cell located in the olfactory epithelium, the patch of nasal tissue that contains odor-detecting olfactory receptor cells. The findings suggest ...

Drugs that stop mosquitoes catching malaria could help eradicate the disease

September 18, 2018
Researchers have identified compounds that could prevent malaria parasites from being able to infect mosquitoes, halting the spread of disease.

Vaccine opt-outs dropped slightly when California added more hurdles

September 18, 2018
In response to spiking rates of parents opting their children out of vaccinations that are required to enroll in school—and just before a huge outbreak of measles at Disneyland in 2014—California passed AB-2109. The law ...

Small molecule plays big role in weaker bones as we age

September 18, 2018
With age, expression of a small molecule that can silence others goes way up while a key signaling molecule that helps stem cells make healthy bone goes down, scientists report.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.